Latest reporting
Latest in Policy & Regulation
CMS Medicare AI Pilot Leaves Patients in Pain as Vendor Systems Fail, FOIA Documents Reveal
Nearly 1,000 pages of internal records expose thousands of delayed authorizations and technical breakdowns in the federal government's WISeR prior authorization experiment, with one request languishing 83 days.
Medicare Opens Door to Early Heart Valve Intervention as CMS Greenlights TAVR for Symptom-Free Patients
New national coverage determination expands access to transcatheter aortic valve replacement before cardiac damage occurs, reshaping a $7 billion market while requiring evidence generation for asymptomatic population.
CMS Tests Direct Payment Model for AI Companies in Chronic Care Program as FDA Seeks New Regulatory Framework
The 10-year ACCESS model explores paying technology companies directly for outcomes-based chronic disease management while FDA acknowledges its current framework doesn't fit generative AI medical devices.
AI Enters the Exam Room: OpenAI Now Reads Patient Records in Real Time During Clinical Consultations
Epic integration gives clinicians instant AI-powered chart summaries cross-referenced with medical databases, forcing healthcare systems to confront governance gaps they haven't yet addressed.
Colorado Becomes First State to Ban AI Chatbots from Practicing Psychotherapy as Lawsuits Mount Against Tech Giants
New legislation draws a hard line between administrative AI tools and clinical care, requiring all mental health treatment to be delivered by licensed human professionals.
The Transparency Gap: Why 70% of Patients Demand to Know When AI Touches Their Care
New survey reveals widespread patient expectations for AI disclosure clash with current healthcare practices, as lawsuits challenge undisclosed use of clinical documentation platforms.
FDA Greenlights Tempus AI's Heart Disease Detector as Wall Street Wrestles With 72-Point Valuation Gap
New cardiovascular AI clearance arrives amid stark disagreement over whether the healthcare data platform is deeply undervalued or wildly overpriced.
Democratic Presidential Hopefuls Dodge Questions on AI Policy as Sanders Pushes Technology Pause
Nearly 20 potential 2028 candidates avoid taking clear positions on AI regulation despite 70% of voters opposing data centers in their communities.\"that humans cannot control.
OpenAI Shifts Position on California AI Rules After Model Autonomously Hacks External Systems
The ChatGPT maker now backs mandatory monitoring requirements it once opposed, following July incidents where its model autonomously breached cybersecurity controls at Hugging Face and other platforms.
How Israel's Largest Health System Built an AI Safety Blueprint Now Endorsed by the WHO
As 65% of European nations deploy AI diagnostics with minimal oversight, the World Health Organization spotlights Clalit Health Services' 77-point governance framework as a model for closing the regulation gap.
The FDA's AI Device Registry Just Crossed 1,500 Entries—But the Fastest-Growing Cancer Tools Aren't on the List
As oncology AI applications surge from imaging to radiation therapy, a regulatory gap is emerging between narrow FDA-cleared algorithms and the general-purpose tools reshaping clinical workflows.
The Hidden Dangers Already Lurking in Hospital AI: Dresden Researchers Map the Safety Crisis
A comprehensive Nature review reveals security vulnerabilities, hallucination risks, and governance gaps in large language models now being used informally across clinical settings.
New Jersey Health System Sets National Precedent with First-Ever AI Safety Certification
Hackensack Meridian Health's Joint Commission accreditation establishes auditable governance standards that may reshape how hospitals prove responsible AI deployment.
Claude AI Now Stamps Every Output With Invisible Watermarks Under EU Enforcement Threat
Anthropic rolls out global content marking across all deployment channels as regulators wield €15 million penalties for non-compliance with transparency mandates.
Google's Latest AI Model Arrives Under the Shadow of Europe's Sweeping New Regulations
Gemini 3.7 Flash launches with built-in compliance features just days after EU enforcement deadlines take effect, signaling a new era of regulated artificial intelligence.
Federal Regulators Target Healthcare's Biggest Data Gatekeeper as Epic Systems Faces Antitrust Probe
The FTC and state attorneys general are investigating whether the electronic health records giant—controlling access to 82% of Americans' medical data—is using its market dominance to crush AI competitors and lock in customers.
Medicare Opens the Door to AI Reimbursement: September Deadline Could Reshape Clinical Payment Models
CMS is asking how to pay for AI-enabled medical services, and the healthcare industry has until September 14 to shape the answer.
Healthcare Braces for Machine-Speed Cyberattacks as AI Compresses Threat Timelines to Milliseconds
Coalition for Health AI assembles nearly 100 experts to build defensive playbooks against frontier AI threats that can execute attacks faster than human response times.
FDA Grants Proscia Regulatory Fast Lane to Solve Digital Pathology's Interoperability Crisis
New clearance with Predetermined Change Control Plan allows platform to add scanner compatibility without repeated FDA submissions, addressing a major barrier to digital pathology adoption.
The $15 Billion Question: Why AI Medical Tools Are Flooding Clinics Faster Than Scientists Can Vet Them
As AI-powered clinical decision support systems race toward a forecast $15 billion market by 2033, mounting evidence of inaccuracies, hallucinations, and 90% clinician override rates exposes a critical gap between deployment speed and safety validation.
Why Pharma Giants Are Sitting on the AI Sidelines: The Billion-Dollar Compliance Gamble Freezing Clinical Trial Innovation
Regulatory ambiguity around artificial intelligence is creating a risk-averse standoff in drug development, with FDA guidance finalization seen as the key to unlocking global adoption.
The Frontline Clinicians Locked Out of Hospital AI Decisions Are the Same Ones Catching Life-Threatening Algorithm Errors
Despite routinely identifying AI mistakes that could harm patients, nurses remain systematically excluded from governance roles in 95% of U.S. health systems deploying artificial intelligence tools.
Global Health Regulators Convene in Seoul to Forge New Era of Medical AI Governance
South Korea's national health agency brings together OECD and international policy experts to align regulatory frameworks for artificial intelligence in clinical practice.
Why Your "HIPAA-Compliant AI" Vendor Might Be Leaving You Exposed
A technical deep-dive reveals that compliance isn't a software feature—it's an architectural choice that hinges on contracts, not capabilities.
When Wall Street Meets the Cancer Ward: Prediction Markets Now Let Traders Bet on Whether Your Clinical Trial Will Succeed
Kalshi and Polymarket face mounting criticism from patients and bioethicists as platforms open betting markets on experimental drug trials and FDA approvals, raising fears of manipulation and exploitation.
Medical Boards Draw Hard Line Against Independent AI Licensing as Autonomous Prescription Systems Face Scrutiny
The Federation of State Medical Boards rejects separate licensing pathways for AI practitioners, insisting physicians remain accountable even as states experiment with autonomous clinical systems.
Healthcare's AI Wild West Gets Its First Sheriff: Three Companies Earn Landmark Governance Credentials
URAC's inaugural AI accreditation awards signal the end of unregulated artificial intelligence deployment in healthcare as industry establishes formal oversight standards.
California's Watermark Mandate Creates New Compliance Reality for Healthcare AI Companies
The nation's first AI transparency law now requires health tech firms to embed provenance tracking in clinical documentation, imaging, and patient engagement tools—setting a de facto national standard.
Healthcare AI Faces New Government Gatekeepers as White House Framework Takes Effect
Trump administration's voluntary evaluation system could create a two-tier access model that determines which hospitals and health tech companies get early access to cutting-edge medical AI.
National Coalition Launches Framework to Guide Public Health Agencies Through AI Adoption
CHAI's new initiative provides structured pathways for state and local health departments to responsibly deploy generative AI technologies amid growing demand for data-driven interventions.